15.92MMarket Cap
0.03P/E TTM
Tempest Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-30The current valuation score of Tempest Therapeutics Inc is 6.63, ranking 309 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is 0.03, which is 88.12% below the recent high of 0.06 and 167657.10% above the recent low of -57.81.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.